Why Parkinson’s?

25 Million People.

That’s the number of people expected to be living with Parkinson’s disease by 2050, according to the latest projections published in The BMJ. It’s a staggering rise—a 55% increase—that underscores what those of us in the field already feel: Parkinson’s is more than a medical condition; it’s a global challenge, growing faster than our current systems can handle.

So why did I choose Parkinson’s?

Because it chose me.
Not in the personal, hereditary sense—I’ve been fortunate that no one in my family has had the disease—but in a deeper way. I first encountered Parkinson’s during high school while researching a project. A CES conference showcasing cutting-edge treatments, especially deep brain stimulation, caught my eye. It wasn’t just the tech that intrigued me; it was the human story behind it. The tremor that couldn’t be controlled. The slowness, the stiffness, the gradual loss of autonomy. But also, the resilience. The hope.

Since then, I’ve dedicated myself to this field. I’ve published and presented research, founded my university’s first Neurology Society, and now serve as a Parkinson’s Foundation Ambassador in the UK. My mission? To bridge research, advocacy, and care—making sure patients are seen, heard, and helped.

Parkinson’s is complex. It’s personal. And it’s rapidly becoming one of the most urgent neurological issues of our time.

That’s why I chose it. And that’s why I’ll never stop.